Duncker Streett & Co. Inc. reduced its stake in Danaher Corporation (NYSE:DHR) by 1.3% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 65,797 shares of the company’s stock after selling 896 shares during the quarter. Danaher Corporation makes up approximately 1.7% of Duncker Streett & Co. Inc.’s investment portfolio, making the stock its 5th biggest position. Duncker Streett & Co. Inc.’s holdings in Danaher Corporation were worth $5,644,000 as of its most recent filing with the SEC.

Other institutional investors also recently made changes to their positions in the company. GQG Partners LLC bought a new position in Danaher Corporation in the 2nd quarter worth $101,000. Proficio Capital Partners LLC raised its holdings in Danaher Corporation by 92.3% during the first quarter. Proficio Capital Partners LLC now owns 1,246 shares of the company’s stock valued at $105,000 after acquiring an additional 598 shares during the period. Monetary Management Group Inc. raised its holdings in Danaher Corporation by 10.7% during the second quarter. Monetary Management Group Inc. now owns 1,550 shares of the company’s stock valued at $131,000 after acquiring an additional 150 shares during the period. Acrospire Investment Management LLC raised its holdings in Danaher Corporation by 185.5% during the second quarter. Acrospire Investment Management LLC now owns 1,693 shares of the company’s stock valued at $143,000 after acquiring an additional 1,100 shares during the period. Finally, ClariVest Asset Management LLC bought a new stake in Danaher Corporation during the first quarter valued at about $157,000. 75.38% of the stock is currently owned by institutional investors.

Danaher Corporation (NYSE DHR) opened at C$92.24 on Monday. The company has a market cap of $64,162.62, a P/E ratio of 23.71, a P/E/G ratio of 2.19 and a beta of 1.02. Danaher Corporation has a 12 month low of C$76.27 and a 12 month high of C$93.36. The company has a quick ratio of 1.00, a current ratio of 1.43 and a debt-to-equity ratio of 0.42.

Danaher Corporation (NYSE:DHR) last issued its quarterly earnings data on Thursday, October 19th. The company reported C$1.00 EPS for the quarter, topping analysts’ consensus estimates of C$0.95 by C$0.05. The company had revenue of C$4.53 billion during the quarter, compared to the consensus estimate of C$4.47 billion. Danaher Corporation had a net margin of 13.36% and a return on equity of 11.29%. Danaher Corporation’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.87 earnings per share. analysts forecast that Danaher Corporation will post 3.99 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Friday, September 29th were issued a $0.14 dividend. This represents a $0.56 annualized dividend and a yield of 0.61%. The ex-dividend date of this dividend was Thursday, September 28th. Danaher Corporation’s dividend payout ratio is currently 16.52%.

In other Danaher Corporation news, insider William King sold 43,688 shares of Danaher Corporation stock in a transaction on Thursday, August 31st. The shares were sold at an average price of C$82.86, for a total value of C$3,619,987.68. Following the transaction, the insider now directly owns 45,748 shares of the company’s stock, valued at C$3,790,679.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of Danaher Corporation stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of C$92.64, for a total transaction of C$11,671,620.96. Following the completion of the transaction, the chief executive officer now directly owns 271,737 shares in the company, valued at C$25,173,715.68. The disclosure for this sale can be found here. Insiders sold 279,628 shares of company stock worth $25,304,394 over the last ninety days. Corporate insiders own 12.20% of the company’s stock.

A number of equities research analysts have commented on DHR shares. Jefferies Group LLC reissued a “buy” rating and set a $95.00 price target on shares of Danaher Corporation in a report on Friday, August 4th. Zacks Investment Research upgraded Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 price objective for the company in a research report on Thursday, October 5th. Cowen and Company restated a “buy” rating and set a $90.00 price objective on shares of Danaher Corporation in a research report on Wednesday, October 4th. Citigroup Inc. set a $96.00 price objective on Danaher Corporation and gave the company a “buy” rating in a research report on Friday, July 21st. Finally, BidaskClub upgraded Danaher Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, July 19th. One analyst has rated the stock with a sell rating, four have given a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. Danaher Corporation currently has an average rating of “Buy” and an average target price of C$93.31.

TRADEMARK VIOLATION NOTICE: “Duncker Streett & Co. Inc. Has $5.64 Million Position in Danaher Corporation (DHR)” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another site, it was copied illegally and republished in violation of US and international trademark & copyright law. The correct version of this story can be read at https://www.thecerbatgem.com/2017/11/13/duncker-streett-co-inc-has-5-64-million-position-in-danaher-corporation-dhr.html.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Stock Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related stocks with our FREE daily email newsletter.